Filing Flows › Orthopediatrics (KIDS) › Trauma and deformity revenue
Orthopediatrics (KIDS) Trauma and deformity revenue by quarter
Orthopediatrics' Trauma and deformity revenue was $52.6M in Q3 2026 (third quarter 2026), 0% from Q2 2026. Over the last 6 quarters it ranged from $37.9M (Q1 2025) to $52.6M (Q2 2026).
| Quarter | Trauma and deformity revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $52.6M | 0% | +19% |
| Q2 2026 | $52.6M | +22% | +26% |
| Q1 2026 | $43.0M | -2% | +14% |
| Q3 2025 | $44.1M | +6% | — |
| Q2 2025 | $41.7M | +10% | — |
| Q1 2025 | $37.9M | — | — |
Q3 2026 at a glance
Orthopediatrics, Q3 2026: revenue $72.7M (+19% year over year), operating margin -5.8%, net loss $5.9M, operating cash flow $4.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Orthopediatrics' Trauma and deformity revenue?
Orthopediatrics' Trauma and deformity revenue was $52.6M in Q3 2026 (third quarter 2026), 0% from Q2 2026.
How has Orthopediatrics' Trauma and deformity revenue changed?
Over the last 6 quarters it ranged from $37.9M (Q1 2025) to $52.6M (Q2 2026).